Bluebird Bio sells itself to Carlyle, SK Capital for less than $30 million Cut-rate price reflects the biotech company’s tumble from soaring heights

https://www.statnews.com/2025/02/21/bluebird-bio-sells-itself-to-carlyle-sk-capital-for-less-than-30-million/